4.6 Article

α7-Cholinergic Receptor Mediates Vagal Induction of Splenic Norepinephrine

Journal

JOURNAL OF IMMUNOLOGY
Volume 186, Issue 7, Pages 4340-4346

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1003722

Keywords

-

Categories

Funding

  1. Hungarian Rosztoczy Foundation
  2. National Institutes of Health [P30DA015663, RO1-GM084125]
  3. Department of Surgery of the New Jersey Medical School
  4. American Heart Association [AHA06352230N]

Ask authors/readers for more resources

Classically, sympathetic and parasympathetic systems act in opposition to maintain the physiological homeostasis. In this article, we report that both systems work together to restrain systemic inflammation in life-threatening conditions such as sepsis. This study indicates that vagus nerve and cholinergic agonists activate the sympathetic noradrenergic splenic nerve to control systemic inflammation. Unlike adrenalectomy, splenectomy and splenic neurectomy prevent the anti-inflammatory potential of both the vagus nerve and cholinergic agonists, and abrogate their potential to induce splenic and plasma norepinephrine. Splenic nerve stimulation mimics vagal and cholinergic induction of norepinephrine and re-establishes neuromodulation in alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR)-deficient animals. Thus, vagus nerve and cholinergic agonists inhibit systemic inflammation by activating the noradrenergic splenic nerve via the alpha 7nAChR nicotinic receptors. alpha 7nAChR represents a unique molecular link between the parasympathetic and sympathetic system to control inflammation. The Journal of Immunology, 2011, 186: 4340-4346.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available